ClinicalTrials.gg
Not yet recruitingNCT07951294Updated Nov 20, 2026

Dry Static Apnoea for Recovery From Acute Laboratory Stress in Trained Breath-Hold Divers

An interventional study of Dry static apnoea and Passive rest with neutral audio in Stress, Psychological and Stress, Physiological, sponsored by Universidad Rey Juan Carlos. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Universidad Rey Juan Carlos · Not applicable, Interventional, and Basic science

How we know

Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 32 studies in Stress, Psychological with a site in Spain — 6 open to participants now, 8 under way, none of them phase 3. Stress, Psychological · Spain.

Planned enrollment
23rd of 25
28 · median 70
Started
2027
the only one that year
No phase
25 of 32
5 open now
Registered
32nd of 32
by date

Among the 32 studies in Stress, Psychological with a site in Spain, this one is the 23rd largest by planned enrollment of the 25 interventional ones that give a count, is the only one that started in 2027, is one of 25 with no phase, and was the 32nd registered.

Stress, Psychological

854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.

Browse Stress, Psychological studies →

Open to participants now

6 of the 32 studies in Stress, Psychological with a site in Spain are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 75 Stress, Psychological studies recruiting now, 34 (45%) set no upper age limit and 37 (49%) stop at 75 or younger; 14 take children under 18; 49 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Stress, Psychological with a site in Spain, or all of them as a file.
02

Study summary

This exploratory randomized controlled trial will test whether a short session of dry static apnoea (voluntary breath-holding while lying down, out of the water) helps trained breath-hold divers recover faster from a brief, standardized laboratory stressor than resting for the same amount of time.

Twenty-eight licensed breath-hold divers will attend a single afternoon session of about 85 minutes. All participants first complete the Maastricht Acute Stress Test (alternating immersion of one hand in cold water at about 2 °C with mental arithmetic and negative feedback). They are then randomly assigned to one of two 24-minute conditions: four supervised dry static apnoeas at 50% of their personal best (maximum 3 minutes each), or lying at rest while listening to a neutral informative audio. Both groups then rest until 60 minutes after the start of the stressor.

The main outcome is salivary cortisol 60 minutes after the start of the stressor. Heart rate, heart rate variability, blood pressure, state anxiety and perceived stress will also be compared between groups.

Read the detailed description

Background. Acute stress activates the hypothalamic-pituitary-adrenal axis, which releases cortisol, and the autonomic nervous system, which raises heart rate and reduces vagal tone. For health, how quickly these responses return to baseline matters as much as their magnitude. Slow, controlled breathing increases vagal modulation and is associated with lower anxiety. Voluntary apnoea shares conscious breathing control and additionally triggers a vagally mediated bradycardia (the diving response), which is also present in dry apnoea. Breath-hold divers often report feeling calmer after training, but this has not been tested with objective markers. To avoid the floor effect of afternoon cortisol, a standardized stressor is applied first and the trial then tests whether apnoea accelerates recovery compared with rest. Trained breath-hold divers are studied because they master the technique and do not find it aversive.

Design. Exploratory, two-arm, parallel-group randomized controlled trial with a blinded outcome assessor. Randomization in blocks of 4, stratified by sex. The outcome assessor is unaware of group allocation; the principal investigator delivers the intervention. Sessions take place in the afternoon (arrival between 15:30 and 17:00) to control for the circadian rhythm of cortisol, at the Faculty of Health Sciences, Alcorcón Campus, Universidad Rey Juan Carlos (Madrid, Spain).

Session (about 85 minutes). Baseline rest and recordings; Maastricht Acute Stress Test (5 minutes of instructions and 10 minutes alternating hand immersion in water at about 2 °C with mental arithmetic aloud and negative feedback); 24-minute intervention; rest until 60 minutes after stressor onset; final debriefing.

Interventions. Experimental group: 4 dry static apnoeas in the supine position at 50% of personal best (maximum 3 minutes), in 5-minute cycles with at least 2 minutes of free breathing between apnoeas, under continuous supervision. Hyperventilation and lung packing are not allowed. Control group: supine rest for the same duration while listening to a neutral informative audio, previously validated with the Self-Assessment Manikin.

Measurements. Four passive-drool saliva samples (S1 at -7, S2 at +22, S3 at +50 and S4 at +60 minutes relative to stressor onset), stored on ice, frozen at -20 °C and analysed in duplicate by ELISA (Demeditec DES6611). R-R intervals and ECG are recorded with a Polar H10 chest strap and analysed with Kubios HRV; blood pressure with an automatic Omron monitor; SpO2 with a finger pulse oximeter. Validated Spanish questionnaires: PSS-14, STAI-Trait, ASI-3 and MAIA-2 (online screening); STAI-6 and a visual analogue scale of stress (four times during the session); Karolinska Sleepiness Scale (end of session). Descriptive and control variables: age, sex, years of practice and personal best; menstrual cycle phase, sleep, caffeine and physical activity on the day of the session.

Statistical analysis. Cortisol will be log-transformed. Primary analysis: ANCOVA of log(S4) with group as factor and log(S1) and log(S2) as covariates. Complementary analysis: linear mixed model (group x time, S1-S4). Autonomic and subjective outcomes will be analysed in the same way, with Holm correction. Sensitivity analyses: stress responders only; adjustment for menstrual cycle phase and sex. Exploratory moderation analyses: trait anxiety, anxiety sensitivity, interoceptive awareness, chronic perceived stress and the cortisol response to the stressor. Effect sizes with 95% confidence intervals will be reported to inform the sample size of a confirmatory trial.

Sample size. As an exploratory trial, no formal power calculation is performed; following the recommendation of at least 12 participants per group for pilot studies (Julious, 2005), 28 participants (14 per group) will be enrolled to allow for losses.

Safety. Apnoeas are performed dry and lying down, which removes the risk of drowning and falls. Heart rate and SpO2 are monitored continuously and the apnoea is stopped if SpO2 falls below 85% or any symptom appears. Participants may remove the hand from the cold water at any time. A written syncope protocol is in place and a defibrillator is available at the faculty.

03

Conditions studied

  • Stress, Psychological
  • Stress, Physiological

Keywords

  • breath-holding
  • apnea
  • freediving
  • diving reflex
  • hydrocortisone
  • salivary cortisol
  • heart rate variability
  • Maastricht Acute Stress Test
  • stress recovery
  • anxiety
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Current breath-hold diving (apnoea) federation licence with insurance
  • Personal best in dry static apnoea of at least 2 minutes

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular, respiratory or endocrine disease, or hypertension
  • to cold exposure (e.g., Raynaud's phenomenon)
  • Use of , beta-blockers or psychotropic drugs
  • Smoking
  • Pregnancy
  • Use of hormonal
  • Periodontal disease
  • Shift work
  • Previous experience with laboratory stressors
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
28 participants (estimated)

Study arms

  • Experimental
    Dry static apnoea

    Participants complete the Maastricht Acute Stress Test and then perform a 24-minute dry static apnoea session, followed by supine rest until 60 minutes after stressor onset.

    Other: Dry static apnoea · Other: Maastricht Acute Stress Test

  • Other
    Passive rest

    Participants complete the Maastricht Acute Stress Test and then rest for 24 minutes listening to a neutral audio (time-matched control), followed by supine rest until 60 minutes after stressor onset.

    Other: Passive rest with neutral audio · Other: Maastricht Acute Stress Test

Interventions

  • OtherDry static apnoea

    Four dry static apnoeas in the supine position, each lasting 50% of the participant's personal best (maximum 3 minutes), in 5-minute cycles with at least 2 minutes of free breathing between apnoeas. Hyperventilation and lung packing are not allowed. Continuous supervision by an investigator trained in apnoea and first aid, with heart rate and SpO2 monitoring; the apnoea is stopped if SpO2 falls below 85% or any symptom appears.

  • OtherPassive rest with neutral audio

    Supine rest listening through headphones to a neutral informative audio, previously validated as emotionally neutral with the Self-Assessment Manikin. No breathing instructions are given.

  • OtherMaastricht Acute Stress Test

    Standardized laboratory stressor: 5 minutes of instructions followed by 10 minutes alternating periods of 45-90 seconds with one hand immersed in water at about 2 °C with periods of mental arithmetic aloud with negative feedback. Participants can remove the hand at any time. Debriefing at the end of the session.

    Also known as: MAST

06

What researchers measure

Primary outcomes

  1. Salivary cortisol 60 minutes after stressor onset (S4)

    Time frame: 60 minutes after the start of the stressor (S4), within the single experimental session; samples at 7 minutes before (S1) and 22 minutes after (S2) stressor onset are used as covariates

Secondary outcomes

  1. Salivary cortisol across the session

    Time frame: 7 minutes before (S1) and 22 (S2), 50 (S3) and 60 (S4) minutes after stressor onset, within the single experimental session

  2. Heart rate

    Time frame: Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session

  3. Heart rate variability (RMSSD)

    Time frame: Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session

  4. Systolic and diastolic blood pressure

    Time frame: Three measurements during the single experimental session: baseline, after the stressor and at the end of the session (60 minutes after stressor onset)

  5. State anxiety (STAI-6)

    Time frame: Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session

  6. Perceived stress (visual analogue scale)

    Time frame: Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session

  7. Minimum peripheral oxygen saturation during apnoeas (apnoea group only)

    Time frame: During each of the 4 apnoeas of the 24-minute intervention period

  8. Minimum heart rate during apnoeas (apnoea group only)

    Time frame: During each of the 4 apnoeas of the 24-minute intervention period

Other outcomes

  1. Sleepiness (Karolinska Sleepiness Scale)

    Time frame: End of the single experimental session (60 minutes after stressor onset)

  2. Number of participants with adverse events

    Time frame: From the start to the end of the single experimental session (about 85 minutes)

07

Study locations

1 site
  • Universidad Rey Juan Carlos, Faculty of Health Sciences, Alcorcón Campus
    Alcorcón, Madrid 28922, Spain
    • Francisco de Asís Fernández Martínez, PhD · Contactfasis.fernandez@urjc.es · +34 91 665 50 60
    • Francisco de Asís Fernández Martínez, PhD · Principal investigator
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Apr 2027, 3 months later.

Of 462 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 3 months is below that.

Counting every sponsor, half of 475 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2026
First posted
Nov 20, 2026
StartEst.
Jan 11, 2027
Primary completionEst.
Apr 30, 2027
CompletionEst.
May 31, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07951294
Responsible party
DeAsís-Fernández, Francisco (Francisco DeAsís-Fernández, Universidad Rey Juan Carlos) — Principal investigator
First posted
Nov 20, 2026
Start date
Jan 11, 2027 (estimated)
Primary completion
Apr 30, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Francisco de Asís Fernández Martínez, PhD
Contact
fasis.fernandez@urjc.es
+34 91 665 50 60
Francisco de Asís Fernández Martínez, PhD
principal investigator · Universidad Rey Juan Carlos

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion